Firebrick Pharma (ASX:FRE)
ASX announcement history & article coverage
Transparent by design.
Announcments by Firebrick Pharma (ASX:FRE) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Results of General Meeting
Nasodine Composition Patent Granted in New Zealand
Cleansing Notice
Application for quotation of securities - FRE
Proposed issue of securities - FRE
Notification of cessation of securities - FRE
Change in substantial holding
Notice of GM & Proxy Form & Access Letter
Cleansing Notice
Application for quotation of securities - FRE
Change of Director's Interest Notice - Peter Molloy
Change of Director's Interest Notice - Stephen Goodall
Close of Offer - Listing Options
Cleansing Prospectus - Listing of Options
Options Top 20 Holders Report
Options Range Report
Application for quotation of securities - FRE
Nasodine patent accepted in Canada
Firebrick investor webinar update
March 2026 Quarterly Activity Report & Appendix 4C
Firebrick Pharma achieves Indonesia approval, launches new product, raises $1.5M for expansion
Notification regarding unquoted securities - FRE
Change in substantial holding - Stephen Goodall
Change in substantial holding - Peter Molloy
Cleansing Notice
Notification regarding unquoted securities - FRE
Notification regarding unquoted securities - FRE
Application for quotation of securities - FRE
Notification of cessation of securities - FRE